Inventor · disambiguated record
Mark R. Herbert
Also filed as: HERBERT MARK R
13 granted patents·10 pending applications·40 citations·filing 2005–2024
89Inventor score
Top patents by PatentIndex Score
23 records- 0194US9340524B2Androgen receptor modulator and uses thereofARAGON PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·25 cites·4 claims
- 0289US2025092011A1Crystalline Forms Of An Androgen Receptor ModulatorARAGON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0385US10934271B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2020·Granted Mar 2, 2021·1 cites·17 claims
- 0485US9481663B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 1, 2016·5 cites·21 claims
- 0584US10308630B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·2 cites·9 claims
- 0683US9399646B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Jul 26, 2016·6 cites·15 claims
- 0778US10766875B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·0 cites·19 claims
- 0877US12018008B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2021·Granted Jun 25, 2024·0 cites·41 claims
- 0977US9994545B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·1 cites·21 claims
- 1072US10556882B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2019·Granted Feb 11, 2020·0 cites·19 claims
- 1172US10526310B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2019·Granted Jan 7, 2020·0 cites·21 claims
- 1265US2010094021A1Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-aminesKALYPSYS INC·Filed 2009·Application pending·0 cites
- 1365US2021177821A1Androgen Receptor Modulator And Uses ThereofARAGON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1460US9868704B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Jan 16, 2018·0 cites·18 claims
- 1560US2009054304A1Heterocyclic modulators of tgr5 for treatment of diseaseKALYPSYS INC·Filed 2008·Application pending·0 cites
- 1657US2007123572A1Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-aminesKALYPSYS INC·Filed 2006·Application pending·0 cites
- 1756US2016220548A1Androgen receptor modulator and uses thereofARAGON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1846US2008221161A1Heterocyclic modulators of tgr5 for treatment of diseaseKALYPSYS INC·Filed 2008·Application pending·0 cites
- 1946US2007155746A1Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinasesKALYPSYS INC·Filed 2006·Application pending·0 cites
- 2045US9783503B2Crystalline forms of an estrogen receptor modulatorGENENTECH INC·Filed 2015·Granted Oct 10, 2017·0 cites·28 claims
- 2143US2007155764A1Novel substituted pyrimidinyloxy ureas useful as inhibitors of protein kinasesKALYPSYS INC·Filed 2006·Application pending·0 cites
- 2237US2007197609A1Salts of inducible nitric oxide synthase dimerization inhibitorsKALYPSYS INC·Filed 2006·Application pending·0 cites
- 2336US7825256B2Inducible nitric oxide synthase dimerization inhibitorsKALYPSYS INC·Filed 2005·Granted Nov 2, 2010·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Mark R. Herbert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →